News | Women's Health | October 11, 2016

vRad and Cisco Launch First Live Video Diagnostics Solution for Mammography

Medical Center Hospital in Texas complements women’s health services with full roster of on-demand breast imaging specialists through video technology

vRad, Virtual Radiologic, Cisco, Live Video Diagnostics, teleradiology, breast imaging, mammography, RSNA 2016

October 11, 2016 — vRad (Virtual Radiologic) announced that it has implemented its first breast imaging Live Video Diagnostics solution site at the Center for Women’s Imaging at Medical Center Hospital (MCH) using Cisco technology.

MCH is a 402-bed regional medical center providing advanced medical services to over 100,000 patients in Odessa, Texas, and the surrounding 17 counties. The solution improves MCH’s mammography coverage and workflow by connecting vRad’s fellowship-trained breast imaging physicians with MCH technologists and patients, helping them to communicate in real time, which leads to faster, personalized and compassionate care when MCH’s onsite breast imaging physicians are unavailable.

Breast imaging patients often experience much tension and anxiety; MCH’s goal is to provide more women with imaging results, quality care and peace of mind as quickly as possible. On designated workdays, vRad’s fellowship-trained, board-certified breast imaging teleradiologists are available at video-enhanced workstations powered by Cisco technology to consult directly with MCH mammography technologists in order to collaborate and review images and radiologist annotations in real time. Consequently, more patients have a better overall experience with higher specialist availability, shorter appointments, minimal wait times for results and fewer callbacks for additional screening.

“Having technologists and patients speaking face-to-face with a radiologist is priceless,” said Carol Evans, RT (R), divisional director of radiology at Medical Center Hospital. “Since we implemented the Live Video Diagnostics program, we have, on average, decreased the duration of patient appointments from about 90 minutes to 30-45 minutes. The new solution site allows us to provide results almost immediately — we either release the patients or, if there is an issue, we send the results to their physician within hours, not days. This significantly improves the overall experience, care and satisfaction for our patients. The additional on-demand coverage to complement our onsite clinicians, as well as the time savings also have allowed us to make more time available to schedule additional patients, which is a great benefit to the women of our community and our hospital.”

The vRad solution site includes Cisco TelePresence technology and end-to-end Cisco network architecture, which prioritizes and carries video traffic with great accuracy in high-definition (HD) formats. This helps enable real-time:

  • Video conferencing between vRad’s fellowship-trained breast imaging specialists, technologists and patients;
  • Sharing of complex mammography images; and
  • Annotating images to articulate and communicate problem areas or findings.
     

“We see great opportunity in our collaboration with vRad and already have commitment to expand Live Video Diagnostics capabilities to additional hospital sites in California and Virginia. We also are working to expand the solution into additional specialties to change how healthcare is delivered,” said Barbara Casey, global healthcare and life sciences director at Cisco.

For more information: www.vrad.com

Related Content

Researchers developed a deep learning model that identifies imaging biomarkers to predict a patient’s risk for developing breast cancer

A deep learning model was developed that combined imaging and traditional risk factors.

News | Mammography | November 30, 2020
November 30, 2020 — Researchers at Massachusetts General Hospi...
Videos | Remote Viewing Systems | November 28, 2020
Konica Minolta’s theme for RSNA 2020 is Depth of Vision. ITN
ProFound AI for DBT offers superior clinical performance when compared to other commercially available breast AI systems
News | Breast Imaging | November 24, 2020
November 24, 2020 — iCAD reported that over 1,000 licenses have been sold as part of...
Densitas Inc., a global provider of A.I. technologies for digital mammography and breast screening, announced its partnership with Mammography Educators to offer the first artificial intelligence powered telehealth technologist training platform to support business continuity in mammography facilities.
News | Mammography | November 20, 2020
November 20, 2020 — Densitas Inc., a global provider of A.I.
Radiologists around the world will have access to a first-of-its-kind online breast density training tool designed to improve radiologists' ability to correctly identify women's breast density categories to comply with the Breast Imaging-Reporting and Data System (BI-RADS), thanks to a collaboration between DetectED-X and Volpara Health. 
News | Breast Density | November 19, 2020
November 19, 2020 — Radiologists around the world will have access to a first-of-its-kind online...
Reduces the complexity of reporting for screening and diagnostic MRI eams to deliver time-saving and patient safety benefits
News | MRI Breast | November 18, 2020
November 18, 2020 — ...
An interview with Professor Christiane Kuhl, M.D., director of radiology, University Hospital Aachen, Germany, on the effects on breast imaging in the COVID-19 era

Getty Images

Feature | Breast Imaging | November 12, 2020 | By Dave Fornell
The pandemic forced many elective procedures, including most areas of...
Images in a 55-year-old woman with a spiculated mass localized in the upper central quadrant (arrow in A, B, D, and E) of right breast detected with digital breast tomosynthesis (DBT) plus synthetic mammography (SM). Breast density was classified as category C with the Breast Imaging Reporting and Data System. Mass was invasive ductal carcinoma, stage I, and was estrogen and progesterone receptor positive and human epidermal growth factor receptor 2 negative. A, Image from SM in craniocaudal view. B, Single

Images in a 55-year-old woman with a spiculated mass localized in the upper central quadrant (arrow in A, B, D, and E) of right breast detected with digital breast tomosynthesis (DBT) plus synthetic mammography (SM). Breast density was classified as category C with the Breast Imaging Reporting and Data System. Mass was invasive ductal carcinoma, stage I, and was estrogen and progesterone receptor positive and human epidermal growth factor receptor 2 negative. A, Image from SM in craniocaudal view. B, Single-slice DBT image in craniocaudal view. C, Magnification of the lesion depicted in B. D, Image from SM in mediolateral oblique view. E, Single-slice DBT image in mediolateral oblique view. F, Magnification of the lesion depicted in E. Images courtesy of Radiological Society of North America

News | Breast Imaging | November 11, 2020
November 11, 2020 — ...